Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria

Overview of attention for article published in European Journal of Pediatrics, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog

twitter: 6 X users

Readers on

mendeley: 56 Mendeley

Summary Blogs X

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 19,551 followers.

#EuropeanJournalOfPediatrics Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria https://t.co/o3pdLqpDEV

21 Apr 2020

Reply Repost Favourite

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria https://t.co/RNZ8lBDHoW

15 Apr 2020

Reply Repost Favourite

RT @ndanmontero: #bilastina, un antihistamínico de segunda generación, está aprobado en Europa para el tratamiento de la rinoconjuntivitis…

09 Jan 2020

Reply Repost Favourite

#bilastina, un antihistamínico de segunda generación, está aprobado en Europa para el tratamiento de la rinoconjuntivitis alérgica y la urticaria en adultos y niños mayores de 6 años

09 Jan 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.